| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/1997 | US5591724 Method for treating the urinary bladder and associated structures using hyaluronic acid |
| 01/07/1997 | US5591721 Orally administering oligonucleotide with phosphorothioate internucleoside linkage |
| 01/07/1997 | US5591720 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/07/1997 | US5591715 Fatty diester, diamide or diether of polyoxyethylene glycol |
| 01/07/1997 | US5591709 Compositions and methods for treating wounds |
| 01/07/1997 | US5591612 Trehalose-releasing enzyme, and its preparation and uses |
| 01/07/1997 | US5591611 Enzyme which hydrolyzes trehalose end group from remaining partial starch hydrolyzate |
| 01/07/1997 | US5591454 Administering glipizide |
| 01/07/1997 | US5591452 Controlled release formulation |
| 01/07/1997 | US5591450 L-carnitine salt and compositions containing same |
| 01/07/1997 | US5591446 Methods and agents for the prophylaxis of atopy |
| 01/07/1997 | US5591442 Mixture of aliphatic alcohol and glycerol 1-alkyl ether as antiseptics |
| 01/07/1997 | US5591441 Composition for nonspecific cellular immune stimulation |
| 01/07/1997 | US5591423 Pigmentation enhancer and method |
| 01/07/1997 | US5591125 For use in a human body |
| 01/07/1997 | CA2070803C Biodegradable implant material and process for producing same |
| 01/07/1997 | CA2043715C Imidazonaphthyridine derivatives |
| 01/07/1997 | CA2038097C Method and composition for coiontophoresis |
| 01/07/1997 | CA2033497C 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/07/1997 | CA2029050C Sustained release compositions for treating periodontal disease |
| 01/07/1997 | CA2024381C Xanthine compounds |
| 01/07/1997 | CA2011329C Xanthine derivatives |
| 01/07/1997 | CA2008509C Stabilizing system for solid dosage forms |
| 01/07/1997 | CA2005919C N-substituted azaheterocyclic carboxylic acids |
| 01/07/1997 | CA2004606C Process for preparing optically active 2-oxoimidazolidine derivatives |
| 01/07/1997 | CA1338831C 4-thiazolidine-carboxylic acid derivatives |
| 01/07/1997 | CA1338830C Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo- 3-thiolanylthio)-2-penem-3-carboxylic acids |
| 01/05/1997 | CA2180294A1 Method for the preparation of n-substituted 4-ketoproline derivatives |
| 01/03/1997 | WO1997000268A1 Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide |
| 01/03/1997 | WO1997000261A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 01/03/1997 | WO1997000255A1 Tetrahydrofuran antifungals |
| 01/03/1997 | WO1997000251A1 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
| 01/03/1997 | WO1997000249A1 Heterocyclic compounds, their production and use |
| 01/03/1997 | WO1997000245A1 3-hydroxy-2(1h)-pyridinone chelating agents |
| 01/03/1997 | WO1997000243A1 5-aminoalkyl-2-(2-alkoxyphenyl)-pyrrole derivatives having affinity for dopamine d3 receptors and their use in the treatment of psychoses |
| 01/03/1997 | WO1997000242A1 Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 01/03/1997 | WO1997000239A1 Antianginal drug comprising nitroxy derivative as active ingredient |
| 01/03/1997 | WO1997000237A1 Process for the preparation of an n-(2-bromoalkyl)-amide derivate_______________________________________________________________ |
| 01/03/1997 | WO1997000078A1 Methods of preventing or treating allergies |
| 01/03/1997 | WO1997000076A1 Compositions containing poly(hexamethylene biguanide) salts and uses thereof |
| 01/03/1997 | WO1997000075A1 Ameliorant for pruritus cutaneous accompanying renal failure |
| 01/03/1997 | WO1997000074A1 USE OF IMIDAZO[1,5-a]QUINOLONES AS NEUROPROTECTIVE AGENTS |
| 01/03/1997 | WO1997000073A1 Novel use for pyrrole derivatives |
| 01/03/1997 | WO1997000072A1 Anti-inflammatory/analgetic composition |
| 01/03/1997 | WO1997000071A1 Androgenic directed compositions |
| 01/03/1997 | WO1997000070A1 Novel medical use |
| 01/03/1997 | WO1997000069A1 Melatonin agonists for treating benign prostatic hyperplasia |
| 01/03/1997 | WO1996037201A3 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY |
| 01/03/1997 | WO1996032003A3 Tetrahydroimidazopyridoindolediones and their use as medicaments |
| 01/03/1997 | WO1996031130A3 Calcium supplements and calcium containing beverages comprising vitamin d |
| 01/03/1997 | WO1996030009A3 Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid |
| 01/03/1997 | CA2225484A1 Androgenic directed compositions |
| 01/03/1997 | CA2225175A1 Novel medical use |
| 01/03/1997 | CA2224707A1 Tetrahydrofuran antifungals |
| 01/03/1997 | CA2224660A1 A pharmaceutical agent for the treatment of pruritus cutaneus associated with renal failure |
| 01/03/1997 | CA2224649A1 Melatonin agonists for treating benign prostatic hyperplasia |
| 01/03/1997 | CA2224555A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 01/03/1997 | CA2224440A1 New vitamin d derivatives with substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents |
| 01/03/1997 | CA2221027A1 Novel use for pyrrole derivatives |
| 01/02/1997 | EP0751144A1 Novel anthracycline prodrugs, method for preparation as well as their use in selective chemotherapy |
| 01/02/1997 | EP0751137A1 Oxaindene derivatives and a process for preparing them as well as medicaments containing them and the use of them |
| 01/02/1997 | EP0751132A1 Pyridazinone derivatives and processes for preparing the same |
| 01/02/1997 | EP0751129A1 Substituted dihydrodibenzo/b, f/azepines, method for their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them |
| 01/02/1997 | EP0751125A1 Esters and amides of 9 (Z)-retinoic acid |
| 01/02/1997 | EP0750913A2 Disaccharide containing freeze-dried preparation for pharmaceutical use |
| 01/02/1997 | EP0750911A1 Composition to reduce cancer incidence and extend lifespan |
| 01/02/1997 | EP0750909A1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence |
| 01/02/1997 | EP0750908A1 Remedy for infectious diseases |
| 01/02/1997 | EP0750907A2 Stable macrolide and macrolide vaccine compositions |
| 01/02/1997 | EP0750906A1 Delta-(s-methylisothioureido)-l-norvaline and cerebrovascular disorder remedy having nitrogen monoxide synthase inhibitor activity |
| 01/02/1997 | EP0750676A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
| 01/02/1997 | EP0750675A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
| 01/02/1997 | EP0750674A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-$g(b)) |
| 01/02/1997 | EP0750673A1 Transgenic production of oligosaccharides and glycoconjugates |
| 01/02/1997 | EP0750640A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same |
| 01/02/1997 | EP0750637A1 Dna encoding cai resistance proteins and uses thereof |
| 01/02/1997 | EP0750628A1 Fibroblast growth factor-10 |
| 01/02/1997 | EP0750621A1 Heterocyclic compounds, their preparation and use |
| 01/02/1997 | EP0750620A1 Carbapenem compounds, compositions and methods of treatment |
| 01/02/1997 | EP0750618A1 Oxazolidinone derivatives and pharmaceutical compositions containing them |
| 01/02/1997 | EP0750617A1 Novel heterocyclic ethanolamine derivatives with beta-adrenoreceptor agonistic activity |
| 01/02/1997 | EP0750616A1 Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds |
| 01/02/1997 | EP0750614A1 Quinazolinyl-amino derivatives having alpha-antagonist activity |
| 01/02/1997 | EP0750612A1 Acridone-derived bisintercalators as chemotherapeutic agents |
| 01/02/1997 | EP0750611A1 Anilide derivatives as fungicides |
| 01/02/1997 | EP0750609A1 Isoprenyl transferase inhibitors |
| 01/02/1997 | EP0750608A1 Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker |
| 01/02/1997 | EP0750607A1 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity |
| 01/02/1997 | EP0750516A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides |
| 01/02/1997 | EP0750512A1 A medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction |
| 01/02/1997 | EP0750507A1 PROTEASOME REGULATION OF NF-$g(k)B ACTIVITY |
| 01/02/1997 | EP0750505A1 Immunotherapy of cancer with allogeneic lymphocytes |
| 01/02/1997 | EP0750504A1 Use of complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus |
| 01/02/1997 | EP0750503A1 Ribozyme therapy for restenosis |
| 01/02/1997 | EP0750502A1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies |
| 01/02/1997 | EP0750501A1 Combined hormonal contraception pharmaceutical preparation |
| 01/02/1997 | EP0750500A1 Treatment of diabetic nephropathy with valsartan |
| 01/02/1997 | EP0750499A1 Carbanilide anticoccidials |
| 01/02/1997 | EP0750498A1 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne |
| 01/02/1997 | EP0750497A1 Uses of perillyl alcohol and perillic acid methyl ester |